The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

by on 23 de gener de 2023 with No hi ha comentaris
  • Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Mauricio, D., . . . Alonso, N. (2022). The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology, 21(1) https://doi.org/10.1186/s12933-022-01652-z

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *